LOS ANGELES, Sept. 02, 2025 (GLOBE NEWSWIRE) — Ampure Charging Systems (“Ampure”), a worldwide leader in vehicle charging technology backed by Transom Capital (“Transom”), is pleased to announce its acquisition of Power Designers Sibex (“Power Designers”), a leader in industrial charging products and electronics manufacturing based in Crystal River, Florida. The transaction marks a major […]
(TSX:PYR),(OTC US:PYRGF),(Other OTC:PYRGF),(Frankfurt:8PY1), MONTREAL, Sept. 02, 2025 (GLOBE NEWSWIRE) — PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes advanced all-electric plasma processes and sustainable solutions to support heavy industry in their energy transition, emission reduction, commodity security, and waste remediation efforts, announces that it
(NASDAQ:AVIR), BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that members of the Atea management team will participate in a fireside chat at the Morgan Stanley 23rd Annual
New investors NEA and SR One lead round alongside existing investors OrbiMed, F-Prime, NVIDIA and Khosla Ventures CHARM's AI-designed menin inhibitor overcomes resistance mutations with the potential to deliver superior efficacy, durability and safety; clinical development expected to start 1Q 26 Oncology leadership strengthened with appointment of former Syndax CEO Briggs Morrison, M.D. and Kim
Coda Octopus Group Sets Fiscal Third Quarter 2025 Earnings Conference Call for Monday, September 15, 2025, at 10 a.m. Eastern Time GlobeNewswire September 02, 2025 Orlando, FL, Sept. 02, 2025 (GLOBE NEWSWIRE) — Coda Octopus Group, Inc. (“CODA” or the “Company”) (NASDAQ: CODA), a global market leader in real-time 3D/4D/5D and 6D imaging sonar technology
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire September 02, 2025 BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that management will participate in the following investor conferences: Morgan Stanley 23rd Annual Global Healthcare Conference
eToro Group to Participate in Upcoming Investor Conferences and Reports Selected July and August Business Metrics GlobeNewswire September 02, 2025 NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) — eToro Group Ltd. (“eToro”, or the “Company”) (NASDAQ: ETOR), the trading and investing platform, today announced that management will participate in the Citi 2025 Global TMT Conference
Kamada to Participate in Upcoming September Investor Conferences GlobeNewswire September 02, 2025 REHOVOT, Israel, and HOBOKEN, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced
Erdene Completes Share Consolidation GlobeNewswire September 02, 2025 HALIFAX, Nova Scotia, Sept. 02, 2025 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN; OTCQB: ERFCF) (“Erdene” or the “Company”) is pleased to announce that further to its news release dated August 25, 2025, the Company has completed the consolidation (the “Consolidation“) of its issued and
AlloFlo(TM) Uveo Achieves Key Milestones Ahead of Launch: 7 Peer-Reviewed Studies & 3,000 U.S. Cases Two new milestone publications confirm robust efficacy and safety profile of bio-Interventional uveoscleral outflow enhancement technology GlobeNewswire September 02, 2025 WHITE PLAINS, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) — Iantrek, Inc. today announced the publication of two new peer-reviewed studies